The preferences of women in Australia for the features of long-acting reversible contraception: results of a discrete choice experiment.


Journal

The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception
ISSN: 1473-0782
Titre abrégé: Eur J Contracept Reprod Health Care
Pays: England
ID NLM: 9712127

Informations de publication

Date de publication:
Oct 2022
Historique:
pubmed: 29 7 2022
medline: 18 10 2022
entrez: 28 7 2022
Statut: ppublish

Résumé

Long-acting reversible contraceptives (LARC), such as intrauterine devices (IUD) and implants, are highly effective. However, the uptake of LARC in Australia has been slow and the oral contraceptive pill (OC) remains the best known and most widely used contraceptive. Our aim was to investigate women's preferences for the features of LARC. We used a discrete choice experiment (DCE) in which each respondent completed 12 choice tasks. We recruited a general population sample of 621 women in Australia aged 18-49 using an online survey panel. A mixed logit model was used to analyse DCE responses; a latent class model explored preference heterogeneity. Overall, 391 (63%) of women were currently using contraception; 49.3% were using an OC. About 22% of women were using a LARC. Women prefer products that are more effective in preventing pregnancy, have low levels of adverse events (including negative effects on mood), and which their general practitioner (GP) recommends or says is suitable for them. Women have strong preferences for contraceptive products that are effective, safe, and recommended by their GP. The results indicate which characteristics of LARCs need to be front and centre in information material and in discussions between women and healthcare professionals.

Identifiants

pubmed: 35899828
doi: 10.1080/13625187.2022.2098947
doi:

Substances chimiques

Contraceptive Agents, Female 0
Contraceptives, Oral 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

424-430

Auteurs

Marion Haas (M)

Centre for Health Economics Research and Evaluation, Faculty of Health, University of Technology Sydney, Broadway, Australia.

Jody Church (J)

Centre for Health Economics Research and Evaluation, Faculty of Health, University of Technology Sydney, Broadway, Australia.

Deborah J Street (DJ)

Centre for Health Economics Research and Evaluation, Faculty of Health, University of Technology Sydney, Broadway, Australia.

Deborah Bateson (D)

Family Planning NSW, Ashfield, Australia.

Jane Fisher (J)

Global and Women's Health, Public Health and Preventive Medicine, Monash University, Melbourne, Australia.

Angela Taft (A)

Judith Lumley Centre, La Trobe University, Melbourne, Australia.

Kirsten I Black (KI)

Department of Obstetrics, Gynaecology & Neonatology, University of Sydney, Central Clinical School, Royal Prince Alfred Hospital, Sydney, New South.

Jayne Lucke (J)

Australian Research Centre for Sex, Health and Society (ARCSHS), La Trobe University, Melbourne, Australia.

Safeera Y Hussainy (SY)

Centre for Medicine Use and Safety, Faculty of Pharmacy and Pharmaceutical Sciences, Monash University, Melbourne, Australia.

Kevin McGeechan (K)

School of Public Health, University of Sydney, Sydney, Australia.

Wendy Norman (W)

Department of Family Practice, University of British Columbia, Vancouver, Canada.

Danielle Mazza (D)

Department of General Practice, Monash University, Notting Hill, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH